Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 341-360 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 341 | NeevCloud lowweak | Opp 1 Risk 1 | Thesis: No positive thesis is supportable because no direct positive evidence survived the 90-day recent evidence window in the retained reviewed sources. Why now: Why now is weak: despite membership rationale referring to partnerships and orbital data center / AI inferencing context, the retained reviewed sources contain zero evidence after recent evidence window and no citable article summaries. Caveats: Phase-2 membership rationale references, and: but no summaries or direct evidence are retained here for factual claims. The reviewed sources itself says NeevCloud is space-adjacent and not clearly a qualifying space company. |
| 342 | Neo Space Group lowweak | Opp 1 Risk 2 | Thesis: Potential opportunity exists if Neo Space Group is a meaningful customer or distribution node for satellite imagery supply to the Saudi government, but the reviewed sources does not provide available direct evidence within the recent evidence window to assess durability or monetization. Why now: No validated near-term or durable timing signal is available in the available evidence. Recency is uncertain because zero after-recent evidence window evidence were available. Caveats: Phase-2 rationale references, but no or summary is provided in the reviewed sources. Counterparty context should not be treated as propagated evidence for Neo Space Group's own thesis. Coverage debug shows zero evidence after recent evidence window. |
| 343 | NewOrbit lowweak | Opp 1 Risk 1 | Thesis: Reviewed evidence rationale says NewOrbit raised a £13.8 million Series A and is building VLEO sovereign communications satellites, but no retained evidence are present here to support a stronger ranked opportunity. Why now: No retained post-recent evidence window evidence are available, so current timing cannot be established from these reviewed sources. Caveats: Only membership rationale supports the company in this screen. No citeable retained evidence after recent evidence window. |
| 344 | OHB SE lowweak | Opp 1 Risk 1 | Thesis: No within the recent evidence window direct positive evidence was available, so there is insufficient reviewed sources support to form a positive 1 year+ opportunity thesis. Why now: There is no retained article or evidence row after the 90-day recent evidence window for OHB SE; recency-based ranking is therefore not supported by the reviewed sources. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Phase-2 cohort membership rationale is not directional evidence and cannot substitute for retained article evidence. Because no article were retained after recent evidence window, no company-specific factual thesis can be cited from these reviewed sources. |
| 345 | Optimized Electrotech Pvt Ltd lowweak | Opp 1 Risk 1 | Thesis: The membership rationale suggests funding and expansion into space-based sensing with initial satellite platform orders, but the reviewed sources provide no retained within the recent evidence window article evidence or to support a positive thesis. Why now: No retained company evidence after the 90-day recent evidence window means there is no evidence-set-backed timing reason to rank this name higher now. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale cites article IDs, and, but no or retained evidence text are available here. Without retained article evidence, absence of bad news is not positive evidence. |
| 346 | Orbex mediumweak | Opp 1 Risk 5 | Thesis: Orbex has only minimal current opportunity evidence in these reviewed sources because the cited article context about its Prime microlauncher predates the 90-day recent evidence window and therefore should not be relied on as current support. Why now: The only surfaced article is dated February 17, 2026, outside the reviewed sources cutoff date of March 29, 2026, and the evidence recent evidence review says both rows were dropped; the article summary said Orbex released new photographs of its microlauncher Prime 'as the company looks to secure a future'. Because this is outside recent evidence window, recency support is absent. Evidence
Caveats: Primary surfaced evidence is outside recent evidence window and should not be treated as current proof. No in-recent evidence window direct positive or negative evidence is available. |
| 347 | OrbitOn lowweak | Opp 1 Risk 1 | Thesis: OrbitOn appears in an external SpaceFund satellite-servicing listing as 'Developing an on-orbit satellite servicing solution,' which is relevant product context, but the article is dated March 4, 2025 and was dropped by the 90-day recent evidence window, so it cannot support a current scored opportunity thesis in these reviewed sources Why now: Why now is weak because the only visible article has March 4, 2025 on a source date basis and the reviewed sources report no current evidence was retained after the March 29, 2026 cutoff Evidence
Caveats: Only article detail shown is outside the 90-day recent evidence window and was dropped. Database/listing style evidence is weaker than company-specific event evidence. External supporting source context is relevance context, not stronger than direct retained evidence. |
| 348 | Palantir Technologies lowweak | Opp 1 Risk 2 | Thesis: This reviewed sources does not provide citable reviewed evidence to support an opportunity thesis for Palantir despite a membership rationale mentioning possible participation in a U.S. Space Force Golden Dome context. Why now: Why now is weak because the reviewed sources references article IDs, and in the membership rationale, but no or reviewed evidence are provided for ranking use. Caveats: High mention count is not conviction. Cohort relevance via Space Force context is not enough without direct event/fact evidence. Coverage debug shows zero evidence after recent evidence window despite large article universe. |
| 349 | Paras Defence and Space Technologies Ltd lowweak | Opp 1 Risk 1 | Thesis: No positive thesis is supported within the reviewed sources' 90-day evidence window. The only cited reviewed sources rationale is older context that the company incorporated a semiconductor subsidiary, but no within the recent evidence window direct positive evidence is available in these reviewed sources. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Paras Defence and Space Technologies Ltd. Caveats: Phase-2 membership rationale references article, but the reviewed sources does not provide or quoted evidence for that item, so it cannot be used as a factual directional citation. No direct positive or negative evidence survived the 90-day recent evidence window. |
| 350 | Parsons Corporation lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only provides older membership context that Parsons has 'space' among technology areas and appears in an SSA market report, but no within the recent evidence window direct positive evidence is available, so no positive thesis is supportable here. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Parsons Corporation. Caveats: Phase-2 membership rationale references articles: and, but the reviewed sources provide no for citation. Article-level market-report inclusion is weaker than direct company-specific operating evidence. |
| 351 | PhysicsX lowweak | Opp 1 Risk 1 | Thesis: Phase-2 rationale says PhysicsX raised $300M, but the reviewed sources characterizes the source as a broad tech funding roundup and provides no retained direct positive evidence inside the 90-day window, so the opportunity case is not currently evidenced. Why now: There is no current catalyst evidence because articles after recent evidence window = 0 and evidence after recent evidence window = 0. Caveats: Funding-round context in rationale lacks -cited retained evidence here. Space relevance is explicitly weak in the reviewed sources rationale. |
| 352 | PierSight lowweak | Opp 1 Risk 1 | Thesis: Insufficient admissible reviewed sources evidence to support a positive thesis within the selected recent evidence window, despite membership rationale describing PierSight as building the Varuna 2.0 SAR and AIS maritime-monitoring satellite. Why now: Why now is unsupported because the reviewed sources show no surviving evidence after recent evidence filtering; there is no direct dated milestone or problem signal to anchor a 1 year+ thesis. Caveats: Only membership-level rationale is present; no citable evidence survived. No direct company-specific positive or negative events are available in the reviewed sources. Low scores reflect evidence scarcity. |
| 353 | Pixxel lowweak | Opp 1 Risk 1 | Thesis: The earlier Pixxel reviewed sources version suggests Earth-observation and fundraising relevance in membership rationale, but there are no retained within the recent evidence window evidence or article summaries to support a current opportunity thesis. Why now: Why now is weak because no articles or evidence were retained after the March 29, 2026 cutoff in these reviewed sources version. Caveats: Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Membership rationale references article IDs without, which cannot be cited as factual support here. |
| 354 | Portal Space Systems lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources' rationale mentions a $50 million Series A and maneuverable spacecraft technology, but no retained within the recent evidence window article evidence is present here to substantiate a positive thesis. Why now: There is no retained evidence inside the 90-day recent evidence window, so no current catalyst or business-state update is citable from these reviewed sources. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale references article IDs, and, but no or retained summaries are supplied. Low score reflects lack of citable evidence, not a negative business judgment. |
| 355 | Precursor SPC lowweak | Opp 1 Risk 1 | Thesis: No positive thesis is supportable from retained evidence. The phase-2 rationale says Precursor SPC uses Spire data for hypersonic tracking and an AI/ML ionospheric nowcasting system tied to article, but the reviewed sources provide no representative article details, quote, or and no retained evidence after recent evidence window. Why now: Why now is weak because the reviewed sources show no available post-recent evidence window evidence; evidence recent evidence review kept_rows is 0 and coverage data articles after recent evidence window is 0. Caveats: Phase-2 rationale references without or retained evidence detail, so it is not sufficient for factual grounding here. No direct positive or negative evidence arrays are populated. Low scores are an evidence-gap judgment, not a business conclusion. |
| 356 | Quantum Opus lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources references older membership support that Quantum Opus helped build a lunar-Earth laser communication terminal used on Artemis II via article, but there is no retained in-window direct positive evidence with to support a current opportunity thesis. Why now: There is no clear why-now catalyst because coverage after the 90-day recent evidence window is empty. Caveats: Membership support exists but no representative article is provided for. No retained evidence after recent evidence window. No direct business-state update, financing, contract, or customer traction evidence is available. |
| 357 | Quantum Systems GmbH lowweak | Opp 1 Risk 1 | Thesis: No direct positive evidence is available. The reviewed sources say Quantum Systems is mentioned only via founders investing in another startup and as a portfolio-company reference, which is not sufficient for a positive company thesis. Why now: There is no supported near-term or long-horizon catalyst in the reviewed sources because zero post-recent evidence window evidence were available. Caveats: Phase2 rationale references article IDs: and: as article context only, but no were provided in the reviewed sources. Coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Context-only mentions and portfolio references cannot substitute for direct positive or negative evidence. |
| 358 | Relativity Space lowweak | Opp 1 Risk 2 | Thesis: Relativity Space has a plausible long-horizon opportunity narrative as a rocket developer with financing context in membership rationale, but the reviewed sources contain no retained evidence within the recent evidence window to support a current opportunity call. Why now: Why now is weak because there are no retained post-cutoff article summaries or evidence in the reviewed sources. Caveats: No retained evidence after recent evidence window. The modest risk uplift reflects uncertainty from lack of current confirmation, not a direct adverse event. |
| 359 | Rocket Factory Augsburg lowweak | Opp 1 Risk 2 | Thesis: The membership rationale mentions focus on a first test launch later in the summer, which could be strategically important, but there is no retained evidence row to support a scored positive thesis. Why now: No retained article or event evidence remains after recent evidence filtering; the only hint is a membership rationale referencing first test-launch focus via article: without an included summary. Caveats: Cannot treat membership rationale alone as strong directional proof. No article summary or retained evidence row is included for article |
| 360 | Rogers Communications Inc. lowweak | Opp 1 Risk 1 | Thesis: Only a very weak opportunity read is possible: the reviewed sources rationale says Rogers was mentioned as a Starlink telco partner in a SpaceX IPO article, implying possible exposure to direct-to-device or satellite connectivity, but no in-recent evidence window company evidence or citable article summary were available for Rogers in these reviewed sources. Why now: There is no available 90-day evidence for Rogers in these reviewed sources; coverage data shows zero article ids after recent evidence window and zero evidence after recent evidence window, so there is no supported 'why now' catalyst in the provided evidence. Caveats: No direct positive or negative evidence were available after the 90-day recent evidence window for Rogers. Phase2 rationale references support references including: but no article or article summary for that item is included in these reviewed sources, so it cannot be cited as factual evidence. Opportunity score is kept near zero because the evidence standard require positive evidence, not mere absence of risk. |
Risk view
Showing rows 301-320 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 301 | Hensoldt AG lowweak | Opp 1 Risk 1 | Thesis: There is no direct negative evidence in the reviewed sources after recent evidence window, so a material risk thesis is unsupported. Why now: No near-term or durable catalyst is established from the available evidence. Coverage debug shows 69 article IDs considered but 0 after recent evidence window and 0 evidence after dedupe. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Only context-level market-list mention is described, not a direct event or fact. |
| 302 | HEO USA lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available. The main risk is that the available evidence is too indirect to establish HEO USA's own operating momentum or strategic durability. Why now: Why now is weak because the cited technical-performance context is indirect, and the reviewed sources explicitly warns that relations are context-only and should not be used as counterparty propagation evidence. Caveats: No current evidence is provided for: and Counterparty/component context is not strong direct evidence for HEO USA itself. Zero evidence available after recent evidence window. |
| 303 | Hermeus Corporation lowweak | Opp 1 Risk 1 | Thesis: No direct adverse evidence is available, leaving no support for a material risk thesis other than evidence scarcity. Why now: There is no current timing signal from the reviewed sources. Coverage debug shows 29 article IDs considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID, but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. The only described mention is indirect article context. |
| 304 | Hula Earth lowweak | Opp 3 Risk 1 | Thesis: No material adverse evidence is shown. Main risk is execution and classification ambiguity rather than documented negative business events. Why now: The only dated retained context is a Startup Intros profile with April 16, 2026, stating Hula Earth uses IoT sensors and satellite imagery and had raised €1.6 million in seed funding; that is recent enough for a 1 year+ watchlist but too weak for a high-conviction thesis. Evidence
Caveats: Evidence is weak context and supporting article context, not direct company event/facts. The funding itself is described as having occurred in November 2024 inside an April 16, 2026 profile, so exact recency of the financing event is older than the profile date. Reviewed evidence itself says Earth observation fit is plausible but not strong from these reviewed sources alone. |
| 305 | Impulso lowweak | Opp 1 Risk 1 | Thesis: No direct adverse evidence is available. The only risk is uncertainty from insufficient company-specific information. Why now: No timing catalyst is supported by the reviewed sources. Coverage debug shows 1 article considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Counterparty context cannot be propagated into a direct thesis. |
| 306 | Infinite Orbits lowweak | Opp 1 Risk 1 | Thesis: Main risk is evidentiary: there is insufficient recent company-specific evidence in the reviewed sources to validate business progress, customer traction, or execution status. Why now: There is no qualifying 90-day retained evidence. The only cited article mentioning Infinite Orbits is dated September 16, 2025, outside the reviewed sources' 90-day recent evidence window, so recency for any business progress is not established. Caveats: Reviewed evidence shows zero evidence retained after recent evidence window. Do not use the older TechCrunch article as current recency proof. Absence of recent negative evidence is not positive evidence. |
| 307 | Innoseis lowweak | Opp 2 Risk 1 | Thesis: No material adverse evidence is provided. The main risk is evidentiary: the reviewed sources does not clearly establish business category fit, operating traction, or near-term durability. Why now: Potentially relevant because the article context references funding and lunar-measurement selection, but the reviewed sources provide no dated evidence or, so recency and sequence cannot be verified beyond the membership rationale tied to Caveats: No current evidence is provided for cited Zero evidence available after recent evidence window despite the membership rationale. Funding and technology-selection references are article-context level only here. |
| 308 | Integrate lowweak | Opp 1 Risk 1 | Thesis: No current material adverse thesis is supportable within the reviewed sources' retained recent evidence window evidence. Why now: Why now is weak because the only specific company article summary in the reviewed sources were dated February 23, 2026 and was dropped by the 90-day recent evidence window, so it cannot support current ranking despite mentioning financing and a Space Force contract, February 23, 2026). Caveats: The reviewed sources contain a representative article summary for stating Integrate 'closed a $17M Series A and landed a $25M space force contract to deploy secure program management software,' but the evidence recent evidence review says those rows were dropped as older than the March 29, 2026 cutoff, so they are not usable for current scoring. The company may be space-adjacent software rather than a direct space operator, per the reviewed sources' own membership rationale. |
| 309 | Integrated Launch Solutions, Inc. lowweak | Opp 1 Risk 1 | Thesis: No material negative thesis can be supported from retained evidence because the reviewed sources contain no direct negative rows within the recent evidence window. Why now: No current catalyst is evidenced in retained rows. Caveats: Phase-2 rationale says ILS provides engineering, mission design, range integration, and support for the STARLAUNCH pathway and cites: and: but neither summary nor is available here for citation. Coverage debug shows 7 articles considered and 0 after recent evidence window. Service-provider context alone is not directional proof without retained positive or negative evidence. |
| 310 | Integrity ISR lowweak | Opp 1 Risk 1 | Thesis: No material risk thesis can be supported because there is no retained direct negative evidence within the reviewed sources' recent evidence window. Why now: No current business change or catalyst is evidenced in the retained rows. Caveats: Phase-2 rationale references: about analysis of satellite maneuvers near an ICEYE satellite, but no or article summary is provided here for citation. Coverage debug shows 1 article considered and 0 after recent evidence window. Single-article descriptive context in phase-2 rationale is weaker than direct event/fact evidence and is uncitable here due to missing. |
| 311 | Intelsat lowweak | Opp 2 Risk 1 | Thesis: There is no material direct negative evidence in the reviewed sources. Main risk is evidence insufficiency rather than a documented adverse business development. Why now: Why now is weak because coverage data shows 0 article IDs after recent evidence window and 0 evidence available after recent evidence window, so timing and durability cannot be validated from these reviewed sources. Caveats: Membership rationale cites article IDs: and: but the reviewed sources provide no or summaries for them. Evidence recent evidence review shows kept_rows 0 and undated_rows_kept 0, so there is no usable direct evidence inside the ranking window. Cannot treat cohort membership as thesis attractiveness. |
| 312 | iQPS lowweak | Opp 2 Risk 1 | Thesis: No direct adverse evidence is present; the key risk is lack of retained post-recent evidence window evidence confirming launch cadence, financing, or customer demand. Why now: Why now is limited because the support is only referenced through membership rationale citing articles and, but the reviewed sources provide no or retained evidence after recent evidence window. Caveats: No or article summaries are provided for cited support articles and. Coverage data shows zero retained evidence after recent evidence window. Potentially interesting launch-agreement signal cannot be scored highly without direct reviewed sources evidence. |
| 313 | Island Green Capital lowweak | Opp 0 Risk 1 | Thesis: No direct adverse event is available, but evidence insufficiency and unresolved identity make it unsuitable for a directional opportunity call. Why now: No timing-based catalyst is supported because no post-recent evidence window evidence were available. Caveats: Phase2 rationale references article IDs: and: but no were provided in the reviewed sources. Reviewed evidence states summaries were about Molten Ventures and Isar Aerospace rather than clearly about Island Green Capital. Context-only mentions cannot support propagation. |
| 314 | Israel Aerospace Industries lowweak | Opp 1 Risk 1 | Thesis: No admissible direct negative evidence was available inside the 90-day recent evidence window, so there is no supportable adverse thesis from these reviewed sources alone. Why now: There is no usable current evidence in the reviewed sources for this company: evidence recent evidence review no current evidence was retained and coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale references article: but no company-specific evidence are available for ranking use. unavailable in reviewed sources. Caveats: Reviewed evidence provides no post-recent evidence window evidence. Membership rationale is not directional proof. Referenced: has no in the reviewed sources. |
| 315 | Karman Holdings Inc. lowweak | Opp 2 Risk 1 | Thesis: No direct negative evidence is available. The primary risk is that the available context is too generic to prove durable space-specific positioning or a differentiated 1 year+ thesis. Why now: Why now is weak because there are no retained evidence after the 90-day cutoff date of March 29, 2026, despite multiple older considered articles. Caveats: No current evidence is provided for and. Revenue facts are referenced only in the membership rationale, not available as direct evidence. Broad supply-chain context is weaker than company-specific contract or product evidence. |
| 316 | Kepler Communications lowweak | Opp 1 Risk 1 | Thesis: No material negative evidence is available. The low risk score reflects missing evidence rather than a proven absence of business risk. Why now: There is no scoreable current catalyst because the reviewed sources contain no reviewed evidence after the 90-day recent evidence filter for this company. Caveats: Membership rationale cites, and, but the supporting article details are not available here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. No current dated evidence means recency is uncertain. |
| 317 | Kessler Dynamics lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available in the reviewed sources after recent evidence filtering, but absence of evidence is not evidence of low risk; practical ranking risk is mostly informational opacity. Why now: There is no usable dated catalyst evidence in the reviewed sources for the 1 year+ horizon. The reviewed sources show 0 reviewed evidence after the 90-day cutoff and no representative article summary or for direct citation. Caveats: Coverage is effectively empty after recent evidence filtering: evidence recent evidence review shows kept_rows 0 and coverage data shows evidence after recent evidence window 0. The reviewed sources references support references including: but no or quote/summary is provided, so it cannot support factual claims under the citation rule. |
| 318 | KinetX lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is available, so there is no supportable risk thesis from these reviewed sources alone. Why now: The only described context is that Intuitive Machines 'closed KinetX transaction' in article, but no business description, no, and no evidence are available after recent evidence filtering. Caveats: Acquisition context alone is not directional proof for KinetX. No company-specific operating facts are available. Referenced has no in the reviewed sources. |
| 319 | Kratos Defense & Security Solutions Inc. lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is retained in the reviewed sources within the recent evidence window, so there is no grounded negative thesis beyond general uncertainty from lack of current evidence. Why now: Why now is weak because no article summaries or direct evidence were retained after the March 29, 2026 cutoff; recency is therefore insufficiently supported in these reviewed sources. Caveats: Membership rationale references support references and, but no article or retained evidence are provided, so they cannot be cited as factual support under the output rules. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. |
| 320 | Kurs Orbital lowweak | Opp 2 Risk 1 | Thesis: Current reviewed sources evidence does not show material adverse developments; the main risk is evidentiary uncertainty rather than a documented company setback. Why now: The only retained evidence is an undated external sector index listing Kurs Orbital as operating in in-orbit servicing, so timing and recency are uncertain. Evidence
Caveats: Evidence is undated and the reviewed sources explicitly says undated external evidence is relevance context, not recency proof. Same-article repeated rows are not independent confirmation. No financing, contract, revenue, product milestone, or regulatory evidence is provided. |